[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK113248B - Fremgangsmåde til fremstilling af med en eller flere mono- eller dihydroxyalkylgrupper substitueret dekstran. - Google Patents

Fremgangsmåde til fremstilling af med en eller flere mono- eller dihydroxyalkylgrupper substitueret dekstran.

Info

Publication number
DK113248B
DK113248B DK385164AA DK385164A DK113248B DK 113248 B DK113248 B DK 113248B DK 385164A A DK385164A A DK 385164AA DK 385164 A DK385164 A DK 385164A DK 113248 B DK113248 B DK 113248B
Authority
DK
Denmark
Prior art keywords
mono
preparation
dihydroxyalkyl groups
dextran substituted
dextran
Prior art date
Application number
DK385164AA
Other languages
English (en)
Inventor
G Flodin
K Granath
B Ingelman
C Johansson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of DK113248B publication Critical patent/DK113248B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK385164AA 1963-09-02 1964-08-04 Fremgangsmåde til fremstilling af med en eller flere mono- eller dihydroxyalkylgrupper substitueret dekstran. DK113248B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE958163 1963-09-02

Publications (1)

Publication Number Publication Date
DK113248B true DK113248B (da) 1969-03-03

Family

ID=20277017

Family Applications (1)

Application Number Title Priority Date Filing Date
DK385164AA DK113248B (da) 1963-09-02 1964-08-04 Fremgangsmåde til fremstilling af med en eller flere mono- eller dihydroxyalkylgrupper substitueret dekstran.

Country Status (7)

Country Link
US (1) US3453364A (da)
AT (1) AT269174B (da)
CH (1) CH473841A (da)
DE (1) DE1443406A1 (da)
DK (1) DK113248B (da)
FR (1) FR3515M (da)
GB (1) GB1015279A (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2041636A1 (de) * 1970-08-21 1972-02-24 James Ellingboe Polysaecharide und Verfahren zur Herstellung
US5693625A (en) * 1989-03-09 1997-12-02 Therapeutiques Substitutives Method of regenerating cells and tissues using functionalized dextrans
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
EP2666493B1 (en) 2005-02-07 2020-09-23 Hanuman LLC Platelet rich plasma concentrate apparatus
WO2006086201A2 (en) 2005-02-07 2006-08-17 Hanuman Llc Platelet rich plasma concentrate apparatus and method
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
WO2008127639A1 (en) 2007-04-12 2008-10-23 Biomet Biologics, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2567692B1 (en) 2008-02-27 2016-04-06 Biomet Biologics, LLC Use of a device for obtaining interleukin-1 receptor antagonist rich solutions
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2749277A (en) * 1953-05-29 1956-06-05 Ohio Commw Eng Co Dextran compound coated body powder

Also Published As

Publication number Publication date
US3453364A (en) 1969-07-01
FR3515M (fr) 1965-08-30
GB1015279A (en) 1965-12-31
AT269174B (de) 1969-03-10
CH473841A (de) 1969-06-15
DE1443406A1 (de) 1968-10-31

Similar Documents

Publication Publication Date Title
DK113248B (da) Fremgangsmåde til fremstilling af med en eller flere mono- eller dihydroxyalkylgrupper substitueret dekstran.
DK108500C (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK111889B (da) Fremgangsmåde til fremstilling af 3-N-substituerede tricycloundecaner.
DK106735C (da) Fremgangsmåde til fremstilling af benzensulfonylsemicarbazider eller salte deraf.
DK106185C (da) Fremgangsmåde til fremstilling af 17α-acyloxy-4,6-pregnadien-20-oner.
DK120596B (da) Fremgangsmåde til fremstilling af acetoxymethylbenzylpenicillinat.
DK108309C (da) Fremgangsmåde til fremstilling af 3-sulfanilamido-isoxazoler eller salte deraf.
DK107031C (da) Fremgangsmåde til fremstilling af 2-halogenmethyl-quinazolin-3-oxider.
DK105592C (da) Fremgangsmåde til fremstilling af substituerede 5-fluor-pyrimidiner.
DK104571C (da) Fremgangsmåde til fremstilling af trans-2-phenyl-3-methylmorpholin.
DK115327B (da) Fremgangsmåde til fremstilling af hydroxyphenylalkylphosphonater.
DK113991B (da) Fremgangsmåde til fremstilling af 2-chlor-3-oxo-butanamider.
DK122883B (da) Fremgangsmåde til fremstilling af ω-lactamer.
DK105591C (da) Fremgangsmåde til fremstilling af 4-karboxyalkylmerkapto-5-aryl-pyrimidiner eller salte deraf.
DK108499C (da) Fremgangsmåde til fremstilling af 1-alkyl- eller 1-hydroxyalkyl-5-nitro-imidazol-2-carboxamider.
DK120764B (da) Fremgangsmåde til fremstilling af 2-amino-5-nitro-benzophenoner.
DK112381B (da) Fremgangsmåde til fremstilling af 16-fluormethylen-17α-hydroxy-20-keto-steroider af pregnan-, 19-nor-pregnan- eller iso-pregnanrækken eller 17α-estere deraf.
DK105922C (da) Fremgangsmåde til fremstilling af pyridyl-2-methylen-aminoguanidiner eller salte heraf.
DK108365C (da) Fremgangsmåde til fremstilling af tetrahydrothiapyranylbenzensulfonylurinstoffer eller salte deraf.
DK105983C (da) Fremgangsmåde til fremstilling af 2-alkoxy-5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK129243B (da) Fremgangsmåde til fremstilling af 6-demetyltetracykliner.
DK105035C (da) Fremgangsmåde til fremstilling af 18-O-acyl-17-hydroxyyohimbanderivater eller 18-O-sulfonyl-17-hydroxyyohimbanderivater.
DK115470B (da) Fremgangsmåde til fremstilling af 3-aziner af 2α-methyl-17β-hydroxy-5α-androstan- eller -estran-3-oner.
DK114773B (da) Fremgangsmåde til fremstilling af 3-aziner af 2α-methyl-17β-alkanoyloxy-5α-androstan- eller -estran-3-oner.
DK106734C (da) Fremgangsmåde til fremstilling af emetin eller salte deraf.